Clinical trial
A Group-Randomized, Standard-of-Care-Controlled, Crossover Trial Evaluating Nasal Antimicrobial Photodisinfection for the Prevention of Surgical Site Infections
NCT06702878 is registered in ClinicalTrials.gov with Ondine Biomedical Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Group-Randomized, Standard-of-Care-Controlled, Crossover Trial Evaluating Nasal Antimicrobial Photodisinfection for the Prevention of Surgical Site Infections
- Lead sponsor
- Ondine Biomedical Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 27, 2024
- Completion date
- May 7, 2026
- Enrollment
- 4,787 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
anti-infective agents, infections, surgical site infections, surgical wound infection